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Previous studies have shown that mouse adenovirus type-1 (MAV-1) caused a fatal hemorrhagic encephalitis in certain
strains of mice. C57Bl/6 mice exhibited 100% mortality when given as little 103 plaque-forming units (PFU) of MAV, in contrast
to BALB/c mice which were resistant to as many as 106 PFU. Susceptible animals died with a flaccid paralysis on the 3rd
or 4th day after inoculation. The brains and spinal cords of these animals displayed numerous petechial hemorrhages that
were found in virtually all areas of the brain, but were more numerous in white matter. In this paper, immunohistochemistry
and electron microscopy were used to identify the viral target of replication within the CNS of susceptible mice. These
studies showed that the CNS vascular endothelial cell was the primary site of viral replication within the CNS of mice infected
with MAV-1. Characterization of cytokine mRNA levels and disease course in immunodeficient mice revealed that the host
immune response played little, if any, role in the pathogenesis of MAV-1 disease in susceptible mice and was not responsible
for the resistance of BALB/c mice. These results support the conclusion that disease course and outcome in susceptible and
resistant strains of mice were determined primarily by the ability of the virus to replicate within the CNS vascular
endothelium. © 1998 Academic Press
INTRODUCTION
Adenoviruses are nonenveloped, icosahedral double-
stranded DNA viruses with a 30- to 36-kb genome (Lar-
son and Nathans, 1977; Horwitz, 1990b, 1996). They have
been isolated from many different vertebrate species in
which they have been associated with a wide variety of
acute and persistent viral infections (Horwitz, 1990b,
1996; Ishibashi and Yasue, 1984). In humans the most
extensively studied member of this family is HAV-2, a
common cause of minor upper respiratory tract infec-
tions of childhood and sporadic infections in adults and
a frequent cause of latent infections in human adenoids
and tonsils (Horwitz, 1990a, 1996). In wild mouse popu-
lations, adenoviruses are also endemic but, until re-
cently, have only been associated with disease in neo-
natal and suckling laboratory mice (Smith et al., 1986;
Smith and Bartold, 1987), where they induce a fatal dis-
seminated infection with areas of focal necrosis in the
kidneys, heart, spleen, and brain (Ehresman and Hogan,
1986; Hartley and Rowe, 1960; Heck et al., 1972; Lussier
et al., 1987; Van der Veen and Mes, 1974; Wigand, 1980;
Winters et al., 1985). Recently, however, two reports
showed that MAV-1 induces an acute fatal hemorrhagic
encephalitis following intraperitoneal injection in certain
strains of adult mice (including C57Bl/6j, DBA, and CD-1),
whereas other strains (such as BALB/c) were resistant
(Guida et al., 1995; Kring et al., 1995). (BALB/c 3 B6) F1
mice displayed an intermediate susceptibility to MAV-1,
demonstrating an incomplete dominance relationship
between the genetic locus or loci responsible for the
strain differences (Guida et al., 1995). The pathophysiol-
ogy and the determinants of both susceptibility and re-
sistance are not known, but susceptible animals infected
with the virus displayed a characteristic progressive pa-
ralysis accompanied by seizures leading to death be-
tween the 4th and 6th day after infection. Pathological
analysis of the tissues showed extensive petechial hem-
orrhages and associated areas of infarction within the
central nervous system (CNS) and foci of cytolysis in the
spleen. Although evidence for viral replication is found
primarily within the CNS, some other organ systems
have been found to have either evidence of viral replica-
tion without pathology [heart (Guida et al., 1995)] or viral
replication with accompanying pathologic change [intes-
tine (Kring et al., 1995)].
The similarity of the MAV-1 hemorhhagic encephalop-
athy of C57Bl/6 mice to the recently described hemor-
rhagic CNS disease that results from infection of neona-
tal mice with the TR1.3 mutant of MmuLV (Park et al.,
1993, 1994a,b,c) prompted us to examine further the
effects of viral infection on the CNS microvasculature
and the role of the immune response in defining the
pathogenic outcome in susceptible and resistant strains
of mice. A comparison of the clinical, virologic, and
pathologic parameters of MAV-1 infection in C57Bl/6j and1 To whom reprint requests should be addressed. Fax: 1.718.430.8541.
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BALB/c mice indicated that the tissue tropism of MAV-1
is different between the two strains, suggesting differ-
ences in viral receptor expression, tissue permissivity for
MAV-1 infection, or differential efficacy of the innate or
acquired immune response in regulation of viral infec-
tion. C57Bl/6j mice and BALB/c mice are known to differ
in their bias toward a cellular or humoral immune re-
sponse, reflecting a predominantly Th1- or Th2-type cy-
tokine profile in cells involved in both innate and ac-
quired immunity (Raj et al., 1992). A critical role for the
immune response in defining susceptibility to viral infec-
tions has been well established, with some viruses being
controlled by cell-mediated immune responses and oth-
ers by humoral immune responses (Coutelier et al.,1995).
In addition, it is also known that components of the
innate immune response, including the recognition of
infected cells by NK cells, macrophages, and/or T cells,
as well as elements of the stress response, play an
important role in defining susceptibility to viral infections
(Winters et al., 1985b). To address these issues with
respect to the susceptibility or resistance to MAV-1 in
adult mice, we have used a combination of immunohis-
tochemistry and electron microscopy to define sites of
viral replication in the CNS and infection of various im-
munocompromised animals to define the contribution of
components of the innate and acquired immune re-
sponse to determine potential differences between the
two strains and its effect on viral replication.
RESULTS
Immunohistochemical localization of viral antigen
In previous studies we showed by analysis of MAV-
E1A mRNA expression in tissue from B6 mice that the
highest levels of MAV-1 E1A expression occurred in the
brain and spinal cords of animals 4 days postinfection
(p.i.) with 5 3 103 PFU of MAV (Guida et al., 1995). Lesser
amounts were noted in the spleen, lung, and heart tis-
sues; other tissues examined (liver and kidney) con-
tained undetectable levels of MAV-E1A expression
(Guida and Horwitz, unpublished observations). Similar
results were obtained with the fiber mRNA probe (data
not shown), indicating that, in tissues in which viral
genes were being expressed, both early and late tran-
scripts were present. In contrast, in tissues taken from
BALB/c mice at the same time point (day 4) only low
levels of MAV-E1A could be detected and only in the
heart, equivalent to that found in the heart from B6
animals.
In order to identify the site of viral replication within the
brains of MAV-1-infected mice, tissue sections from B6
and BALB/c animals were sacrificed at regular intervals
after viral infection and stained with an antibody raised in
rabbits against MAV-1. This antiserum reacts specifically
with MAV-1 structural proteins, with the vast majority of
the immunoreactivity directed at the fiber protein (Figs.
1A and 1B). Preimmunization serum showed no staining
of normal or infected CNS tissues from B6 or BALB/c
mice (Fig. 1C and data not shown), but postimmune
serum reacted strongly with CNS tissue from MAV-1-
infected, moribund C57Bl/6 mice (Fig. 1D).
FIG. 1. Characterization of the rabbit polyclonal antibody to MAV-1.
Western blot analysis of the preimmunization serum (A) and the postim-
munization antiserum (B) tested against L9/29 or L9/29 cells infected
with MAV-1. Note the dominant immunoreactive band at 55 kDa, cor-
responding to the fiber protein of MAV-1. Immunohistochemical analy-
sis of this serum showed that whereas the preimmune serum gave no
immunoreactivity for brain sections taken from C57Bl/6 mice 96 h
postinfection with MAV-1 (C), serial sections from the same mouse
showed strong immunoreactivity associated with the vasculature when
reacted with the postimmunization antiserum (D). Original magnifica-
tion of C and D, 383.
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Serum from the immunized rabbit detected viral anti-
gen within the CNS of MAV-1-infected B6 mice com-
mencing at 48 h postinoculation. At this time point, im-
munoreactivity was restricted to vascular endothelial
cells of veins and small caliber vessels, particularly in
the meninges (Fig. 2A). Interestingly, staining was con-
fined to the meningeal veins, with no evidence of arterial
infection by MAV-1 (Fig. 2A). In these cells, intense stain-
ing was detected in the nucleus and perinuclear areas,
with only light staining of the cytoplasm evident. Apart
from the predominance of reactive vessels in the menin-
ges, no preferential localization of infected veins to spe-
cific areas of the CNS was noted, and no evidence of
pathology within the brain microvasculature was found
at this time point. By 72 h staining of endothelial cell
nuclei had become more intense and more widespread
FIG. 2. Light microscopic analysis of the distribution of MAV-1 immunoreactivity in the CNS of infected animals. In A–C the distribution of
immunoreactivity for MAV-1 in the CNS of C57Bl/6 mice is shown for 48, 72, and 96 h post-ip infection, respectively. At all time points prominent
immunoreactivity for MAV-1 was restricted to the nuclei of cells associated with the vasculature. Evidence of perivascular edema along with vascular
pathology was seen at 96 h (C). In BALB/c mice immunoreactivity for MAV-1 was found in only a few vessels at the 96-h time point (D). In hemotoxylin-
and eosin-stained sections, evidence of neuronal pathology was noted in C57Bl/6 animals 96 h post-ip infection with MAV-1 (E) in areas where little
immunoreactivity for MAV-1 was found (F). Original magnifications: A, 383; B, C, 341; D–F, 320. Arrowheads, immunopositive cells; arrows, vascular
edema; V, vein; A, artery.
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within the brain (Fig. 2B). Contiguous stretches of vas-
culature were positive for viral antigen, with small clus-
ters of virally infected cells present in areas showing the
first signs of pathological change. At this time point
strong immunoreactivity for viral signal was still confined
only to cells with the morphologic appearance of vascu-
lar endothelium. At 96 h p.i., much of the CNS endothe-
lium was positive for viral antigen, and particularly in-
tense staining was found in regions associated with
damage to endothelial cells and hemorrhage (Fig. 2C).
Even at this late time point, the vast majority of the
positive signal was still confined to the vascular endo-
thelium; however, in areas adjacent to damaged vessels
faint staining of cells in the parenchyma of the brain
could be seen (data not shown). This parenchymal stain-
ing was found predominantly in microglia, in a pattern
consistent with phagocytosis of remnants of infected
cells. In some instances, areas of striking neuronal pa-
thology were observed in the absence of significant
amounts of MAV-1 immunoreactivity (Figs. 2E and 2F).
In contrast to the results obtained in the B6 animals,
staining of the brains from MAV-1-infected BALB/c mice
revealed little evidence of viral infection. All mice tested
at and before 72 h were uniformly negative (data not
shown), but at 96 h p.i., rare vascular endothelial cells
were found that were weakly stained with the antibody
(Fig. 2D).
Ultrastructural pathology
Brain tissue from MAV-1-infected BALB/c and B6 mice
was examined by electron microscopy to confirm the site
of viral replication within the CNS and to further charac-
terize the nature of the CNS lesions. These studies were
performed on mice at 96 h p.i. to increase the likelihood
of finding virally infected cells. In tissues taken from B6
animals electron-dense, nonenveloped icosahedral par-
ticles 75 nm in diameter were found singly and aggre-
gated into paracrystalline arrays in the nuclei of cells
within the lumen of the cerebral vasculature (Fig. 3A).
The cytoplasm of the infected cells was swollen and the
nuclei displayed margination of chromatin. In many
cases the cells filled the lumen, occluding the vessel
(Figs. 3A and 3B). In cross sections, it was sometimes
difficult to determine if these cells were vascular endo-
thelial cells or inflammatory cells trapped within the
vascular lumen. However, careful analysis of longitudinal
sections showed that infected cells were closely applied
to a basal lamina on the abluminal surface and main-
tained contact with adjacent endothelial cells (Figs. 3B
and 3C). Although tight-junctional complexes were no
longer clearly evident at these sites (Figs. 3B and 3C), the
ultrastructural studies strongly support the conclusion
that infected cells are endothelial cells.
In many instances, the vessels were in an advanced
state of degeneration and the distinct morphology of the
vascular endothelial cells was no longer discernible.
These vascular elements contained free virus, numerous
platelets, and red blood cells, as well as evidence of
intravascular coagulation (Figs. 4A and 4B). The basal
lamina was frequently intensely stained and the astro-
glial endfoot processes swollen, changes consistent
with an increase in the permeability of the CNS vascu-
lature. Swollen processes of cells that were most prob-
ably astrocytes could be detected throughout the adja-
cent neuropil, and cells with the morphological appear-
ance of highly reactive microglia were present in
involved areas. Hemorrhage was also noted adjacent to
damaged vessels. We attribute these changes to lytic
infection of endothelial cells and to infarction secondary
to vascular occlusion by swollen, infected endothelial
cells.
Pathology found within the CNS of MAV-1-infected
resistant BALB/c mice was limited to microglial activa-
tion and mild inflammatory changes (data not shown). No
viral particles were detected within the CNS of BALB/c
mice.
The results of the immunohistochemical and ultra-
structural pathology studies indicate that, in susceptible
animals (C57Bl/6), the site of viral replication within the
brain is the cerebrovascular endothelial cell and that in
most instances viral replication coincides with pathology
in infected animals. Additionally, the lack of pathology
seen in BALB/c mice paralleled a dramatically reduced
viral load within the CNS of this strain of mouse. These
results imply that much of the pathology produced is the
direct result of the effects of the viral replication on the
target cell and that the resistance seen in the BALB/c
mouse may be the result of a viral replication block seen
in this strain of mouse. There are, however, areas of CNS
damage in C57Bl/6 mice that do not have evidence of
active viral replication. This pathology is most likely the
result of derangement of the CNS blood flow secondary
to the mechanical defects produced in the vasculature by
the effects of viral replication.
Analysis of CNS cytokine levels
Light microscopic analysis of these tissues detected
the presence of small numbers of mononuclear inflam-
matory cells and activated microglia within the brains of
both susceptible and resistant mice by 96 h p.i. (Guida et
al., 1995, and data not shown), suggesting that the host
immune response might contribute to the strain-specific
susceptibility to MAV-1. To determine the extent and type
of the immune response to MAV-1 during the course of
the disease, we analyzed the expression of mRNA for a
variety of cytokines within the CNS of MAV-1-infected
animals. Ribonuclease protection assays (Hobbs et al.,
1993) were used to quantitate the levels of cytokine
mRNA present in the brains of MAV-1-infected mice at
various time points p.i. These studies revealed an in-
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crease in the levels of mRNA for the proinflammatory
cytokines IL-1, TNF-a, LT, and IL-6 commencing at 96 h
p.i. (Fig. 5). Interestingly, little difference was noted be-
tween susceptible and resistant strains of mice. Cytokine
mRNA levels were approximately equal in both resistant
and susceptible mice and were upregulated with the
same kinetics. The cytokine data indicate a generalized
inflammatory response to the viral infection, as expected,
but do not point to an obvious role for the immune
response in either fatal CNS disease or in protection
from disease.
Immune contribution to MAV-1 disease
To further characterize the role of the immune re-
sponse in resistance to MAV-1 encephalopathy, BALB/
scid (Bosma et al., 1983) and immunologically normal
BALB/c mice were infected with 5 3 103 PFU of MAV-1. In
contrast to B6 mice, which typically begin to show clin-
ical disease between days 3 and 5 p.i., BALB/scid mice
did not show clinical evidence of disease until day 6 p.i.
(Fig. 6). The progression of the disease in BALB/scid
animals was different from that of the B6 mice, with
lethargy, ruffled fur, hyperpnea, and conjunctivitis as the
initial symptoms, progressing to extreme lethargy and
death between days 7 and 9 (Fig. 6). No paresis or
paralysis was observed, and none of the animals devel-
oped seizures. This disease course was clearly different
from that observed in B6 mice, where conjunctivitis and
ruffling of the fur were only rarely present, and the dis-
ease was almost invariably accompanied by seizures,
ataxia, paralysis, and death by day 5 or 6 p.i.
The pathologic and virologic findings support the clin-
ical observations that the immunodeficient BALB/c mice
were succumbing primarily to a nonneurologic disease.
Gross and microscopic postmortem analysis of the
BALB/scid mice showed a pale and fatty liver, consistent
with a Reye’s Syndrome-like illness previously reported
for this strain of mouse (Pirofski et al., 1991). There was
focal hemorrhagic enteritis in all of the scid mice, al-
though the extent of this involvement was variable. A
small number of petechial hemorrhages was noted in the
spinal cords of two of five of the scid mice, but the brain
was not involved in any of the animals tested. Immuno-
histochemical staining of liver and spleen tissues from
BALB/scid mice with the polyclonal rabbit anti-MAV-1
antiserum revealed extensive viral replication in hepato-
cytes within the liver (Figs. 7A and 7B). Viral infection of
hepatocytes was first detectable by immunohistochem-
istry at 144 h p.i., when staining was confined to the
cytoplasm (Fig. 7A). By 196 h p.i., intense nuclear staining
was observed in many areas of the liver (Fig. 7B). Wide-
spread staining of cells identifiable by morphologic cri-
teria as macrophages was observed within the spleen by
96 h p.i. (Fig. 7C). Notably, no staining of the vascular
endothelium was observed within these tissues. No
staining was found within the liver or spleen of immuno-
logically normal BALB/c mice (data not shown). In con-
trast, immunostaining of liver and spleen of C57BL/6
mice revealed extensive infection of vasculature within
the spleen (Fig. 7D), but not the liver, by 96 h p.i. (data not
shown).
Distribution of virus within MAV-1-infected BALB/scid
animals was determined by RNase protection assay and
by plaque assay of organs harvested from animals on
days 6 to 8 pi. Viral titers were highest in spleen (2.2 3
105 PFU/g), followed by kidney (2.8 3 103 PFU/g), liver
(2.7 3 103 PFU/g), and brain (8.5 3 102 PFU/g). These
results were concordant with the data from the RNase
protection assay and the immunohistochemical staining,
which revealed the highest amounts of viral RNA in the
spleen, followed by liver, kidney, and brain (data not
shown). Notably, the titer of virus present within the brain
of a BALB/scid mouse at day 6 was 45-fold lower than
the titer of virus present in the brain of B6 mouse on day
4, in agreement with the clinical observations that the
BALB/scid mice were succumbing to a generalized in-
fection that does not specifically target the CNS.
In order to assess the contribution of natural killer (NK)
cells to MAV-1 infection of scid mice, groups of CB.17/
scid/beige mice and CB.17/scid mice as controls were
infected with 5 3 103 PFU of MAV-1. Mice bearing the
beige mutation are deficient in natural killer cell activity.
CB.17 mice are congenic with BALB/c but carry the IgHb
locus from the C57BL/6 genetic background. Since the
IgHb genes are not expressed in mice bearing the scid
mutation, no phenotypic differences between BALB/c
scid and CB.17 scid mice were expected. As with the
BALB/scid mice, the first signs of clinical disease in both
CB.17/scid and CB.17/scid/beige appeared on day 6 p.i.,
and all of the mice died by day 10 p.i. (Fig. 6). Clinical
observations for the three groups were similar, with
ruffled fur, lethargy, and conjunctivitis indicating a gen-
eralized infection involving multiple organ systems.
There were no clearly discernable differences between
the CB.17/scid and CB.17/scid/beige groups, nor be-
tween these mice and the BALB/scid mice previously
described, suggesting that NK cells contribute little to the
resistance to MAV-1 disease seen in BALB/c mice.
FIG. 3. Electron micrographs of the CNS of infected C57Bl/6 mice showing sites of viral replication. At 96 h post-ip infection with MAV-1,
paracrystalline arrays of viral particles with the typical morphology of adenoviruses (insets A and B) were found in the nuclei of cells associated with
the vasculature. Magnifications: A, 37500; inset, 345,000; B, 38000; inset, 322,500; C, 315,000; inset 330,000. Arrowheads, endothelial junctional
complexes; arrows, viral particles; BL, basal lamina; EC, endothelial cell; ECN, endothelial cell nucleus; L, vascular lumen.
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FIG. 4. Electron micrographs of the CNS of infected C57Bl/6 animals showing evidence of vascular pathology. At 96 h post-ip infection with MAV-1
many of the vessels were occluded (A and B) and contained inflammatory cells, platelets (arrows A), and cellular debris (B). Free viral particles were
noted within this cellular debris (higher power inset, B), indicative of lysis of infected cells. Surrounding astrocytic processes were frequently swollen
(asterisks, A) or showed deposition of glycogen (arrowheads, A), changes also indicative of vascular damage. Magnifications: A, 34000; B, 34000,
inset, 330,000.
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Although the BALB/c- and CB.17-derived scid and
CB.17/scid/beige mice were susceptible to lethal
MAV-1 infection, all were resistant to neurologic dis-
semination, CNS hemorrhage, and infarction. This
suggests that B, T, and NK cells are not the critical
elements that serve to protect MAV-1-resistant BALB/c
mice, but does not address the possibility that B
and/or T cells are immunopathic in MAV-1-susceptible
B6 mice. To examine this latter possibility, RAG-12/2
(Mombaerts et al., 1992; Shinkai et al., 1992) mice were
infected with 5 3 103 PFU of MAV-1. RAG-12/2 mice
are both B and T cell deficient and are maintained on
a C57Bl/6 3 CD-1 background, both of which strains
are susceptible to MAV-1-induced encephalopathy
(Guida et al., 1995; Kring et al., 1995). These mice
developed MAV-1 encephalopathy, with clinical signs
and kinetics indistinguishable from those of normal B6
mice (Fig. 6). This strongly suggests that B- and/or
T-cell-mediated immunopathology is not responsible
for the susceptibility of B6 mice to MAV-1.
DISCUSSION
In the present study we have attempted to character-
ize the pathogenesis of the fatal hemorrhagic encepha-
lopathy induced by MAV-1 in susceptible C57Bl/6 mice,
as well as the nature of the resistance seen in BALB/c
mice. The results of these studies indicate that the host
immune response to the infection plays a minor role in
the case of MAV-1 disease of the adult mouse and that
the majority of the observed pathological changes found
in affected mice are the direct result of the effects of viral
replication within the target cell, endothelial cells of the
CNS vasculature.
In the first part of this investigation, we identified the
target cell for MAV-1 replication within the brains of
infected B6 mice as the endothelial cell of the small veins
of the meninges and brain, which provides a plausible
mechanism for the subsequent development of the neu-
rological damage manifested in these animals. Direct
damage to the vascular endothelium secondary to the
replication of the agent sets the stage for the ensuing
series of events that results in extensive cerebral hem-
orrhage, probably occurring by two different, but related,
mechanisms. In the first instance, infection of endothelial
cells leads to a mechanical defect in the microarchitec-
ture of the cerebral blood vessels, with the resultant
rupture of the vessel and escape of fluid and cellular
components of the blood into the surrounding tissue.
Ample evidence for this direct mechanism was detected
by ultrastructural pathology, where deposition of fibrin
and escaped red blood cells were observed in the vicin-
ity of virally infected endothelium. In the second mecha-
nism, infarction, with subsequent reperfusion injury and
further hemorrhage, can be inferred from the light and
electron microscopic studies. The response of the in-
fected vascular endothelial cells to viral infection takes
two forms, swelling and lysis. The swollen or lysed cells
and cell fragments then appear to become lodged in
small-caliber postcapillary venules, resulting in occlu-
sion of the vessel. In several instances virally infected
cells could be seen completely filling the lumen of the
vessel. This process of endothelial thrombus formation
and infarct is also supported by light microscopic evi-
dence of large areas of neuronal pathology consistent
with hypoxic stress. In at least one area (Fig. 4B) vascu-
lar occlusion with concomitant edema, glycogen deposi-
tion in adjacent astrocytic foot processes, and tissue
damage was seen in an area surrounding a degenerat-
ing virally infected cell within the vascular lumen.
Interestingly, viral infection of the cerebrovascular en-
dothelium was limited to veins within the meninges, and
small-caliber, postcapillary venules within the brain.
Whether this reflects a true difference in the tropism of
the virus for these cells over the vascular endothelium of
the arteries and arterioles is not known yet. It is likely,
however that this may simply reflect the differences in
FIG. 5. Cytokine mRNA expression in the brains of MAV-1-infected
mice. Twenty micrograms of total RNA from the brains of MAV-1-
infected and uninfected control mice was assayed at 96 h postinfection
by RNase protection assay for steady-state cytokine mRNA levels with
the ml-11 probe cocktail. This cocktail includes antisense RNA for TNF,
LT, IFNg, IL-1 a and b, IL-2, IL-3, IL-4, IL-5, IL-6, and the control probe,
ribosomal protein L-32. Cytokine-specific bands are indicated on the
left. Lane A, uninfected C57BL/6 mouse; B and C, C57BL/6 mice
infected with MAV-1 96 h p.i.; D, uninfected BALB/c mouse; E and F,
MAV-1-infected BALB/c mice 96 h p.i. IFN-g, interferon-g; IL1-a, IL-1a;
IL1-b, IL-1b.
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the fluid dynamics of the arterial versus the venous blood
flow. Blood flow within the veins is sluggish relative to
the arteries, and the virus may have more time to engage
receptors present on the surface of the venous endothe-
lium, leading to the preferential infection of these cells.
The pivotal role of viral infection of the cerebrovascular
endothelial cell in MAV-1-induced hemorrhagic enceph-
alopathy is supported by the results of studies in the
BALB/c mice that are completely resistant to the devel-
opment of the neurological manifestations of MAV-1. Sig-
nificantly, we were unable to show appreciable infection
of the brain vasculature in these animals. The fact that
viral infection of the brain endothelium does not occur in
this resistant strain of mice bolsters the hypothesis that
infection of these cells is necessary and sufficient for the
development of hemorrhagic encephalopathy.
Previous investigations into the pathogenesis of
MAV-1 have detected viral replication within vascular
endothelium within the heart (Blailock et al., 1967; Heck
et al., 1972), kidneys (Hartley and Rowe, 1960; Heck et al.,
1972), lungs (Winters et al., 1985a), and brain (Heck et al.,
1972) of neonatal mice; however, no correlation has been
made with the subsequent development of hemorrhage
in any of these organs.
A similar pathogenetic mechanism has been pro-
posed in neonatal mice infected with the TR1.3 mutant of
the Friend-related MmuLV, where it has been shown that
viral replication within CNS microvasculature leads to
syncytia formation, with subsequent hemorrhage and
infarction (Park et al., 1993, 1994a,b,c). Characterization
of the disease process revealed that the pathology was
the result of a mutation in the fusogenic envelope glyco-
protein resulting in multinucleate giant cell formation in
vascular endothelial cells (Park et al., 1994c). In an in-
fected animal, these syncytia resulted in mechanical
defects in the vasculature, leading to hemorrhage. The
syncytia also acted as thrombi, occluding small-caliber
postcapillary venules, with the development of additional
CNS damage occurring subsequent to the formation of
infarcts. In this model system, viral infection of neonatal
mice resulted in the production of endothelial syncytia
within the CNS producing a slowly evolving hemorrhagic
CNS disease composed of a two-step process: (1) direct
damage to the endothelial cells resulting in rupture of the
vessel wall and (2) thrombus formation leading to multi-
ple infarcts. The interesting difference between this and
the MAV-1 model system is the time course of the dis-
ease. Whereas the onset of MAV-1 disease can begin
within 48 h of infection, TR1.3 requires 18 days to mani-
fest the first signs of clinical disease. Additionally, TR 1.3
is only pathogenic for neonatal mice, indicating that the
presence of an effective immune response against the
virus may control the development of the disease (Park
et al., 1994a,b).
One explanation for the differential susceptibility of
BALB/c and C57Bl/6 to MAV-1 is that the receptor for the
virus is expressed in a tissue-specific and developmen-
tally regulated manner that is mouse strain dependent. In
this regard, it is interesting to note that genetic resis-
tance to the A59 strain of mouse hepatitis virus (MHV)
FIG. 6. Survival of normal and immunodeficient BALB/c and C57BL/6 mice after infection with MAV-1. Two groups of 5 (N 5 10 for each strain tested)
C57BL/6, C57BL/6/RAG12/2, BALB/c, BALB/scid, CB.17/scid, and CB.17/scid/beige mice were inoculated intraperitoneally with 500 PFU of MAV-1.
Animals were observed daily for morbidity and mortality. B6 and RAG-12/2 (B6) mice displayed characteristic signs of MAV-1 disease, including ataxia,
seizure, and paralysis beginning on day 3 p.i. Neurologic signs were not observed in BALB/c, BALB/c scid, or CB.17 scid, and CB.17 scid/beige
animals, although the immunodefficient mice did become lethargic and develop conjunctivitis on the day prior to death.
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has been shown to correlate with allelic differences in
the N-terminal region of the carcinoembryonic-antigen-
related glycoprotein Bgp1, which has been identified as a
functional receptor for the viral spike glycoprotein (Boyle
et al., 1987; Dveksler et al., 1991; Williams et al., 1991;
Godfraind et al., 1995). The susceptible BALB/c strain
expresses the Bgp1a allele and the resistant SJL/J mouse
the Bgp1b allele. Interestingly, however, the Bgp1a allele
is also expressed by cells that are not infected by MHV,
suggesting that other factors contribute to the uptake
and replication of the virus (Godfraind et al., 1995). Such
a requirement for a multistep process in successful viral
entry and replication has now been well established for
a number of different viruses, including poliovirus (Freis-
tadt et al., 1995) and HIV-1 (Bluel et al., 1996; Huang et al.,
1996; Oberlin et al., 1996). A two-step mechanism has
also been proposed for adenoviruses, with the fibers
projecting from the adenoviral capsid interacting with a
specific cell surface protein, and the penton base inter-
acting with a cell surface integrin, with both participating
in uptake and replication (Mentel et al., 1997; Wickham et
al., 1994, 1995). At the present time, the specific receptor
used by MAV-1 and its distribution between different
mouse strains and different tissues is not known. Re-
cently, a common receptor for human Coxsackie B vi-
ruses and human adenoviruses 2 and 5 was identified
(the Coxsackie and adenovirus receptor, CAR). It is a
46-kDa protein present on the cell surface that mediates
attachment of viral fiber to the cell surface (Bergelson et
al., 1997). However, whether MAV-1 uses a similar recep-
tor that shows both strain- and tissue-specific expres-
sion is not known at the present time.
In the second part of this study, we addressed the role
of the host immune response in defining resistance or
susceptibility to MAV-1. The results of these experiments
clearly showed that the host immune response had little
or no effect on the development of hemorrhagic enceph-
alopathy. Studies of the course of disease in scid (Bosma
et al., 1983) and RAG2/2 (Mombaerts et al., 1992; Shinkai
et al., 1992) mice indicated that the single factor that
predicted resistance to MAV-1-induced cerebrovascular
disease was whether the mouse was of the BALB/c
strain. In the case of RAG2/2 mutation on the B6 back-
ground, the disease course was unchanged relative to
FIG. 7. Light microscopic analysis of the distribution of MAV-1 in liver and spleen. In the BALB/c scid mouse (A and B) immunoreactivity for MAV-1
was detected in the cytoplasm of hepatocytes at 144 h postinfection with MAV-1 (A), which had shifted to the nucleus by the 196-h time point (B). In
the spleen at the 196-h time point (C) immunoreactivity was present in the nuclei of parenchymal spleen cells, most probably macrophages. In
contrast, in the spleens of C57Bl/6 animals at 96 h postinfection immunoreactivity for MAV-1 was associated with the vasculature. Magnifications:
A–D, 383.
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the immune-competent B6 parent. Failure to mount an
immune response did not prevent the development of
CNS hemorrhage, indicating that an immunopathic host
B- or T-cell-mediated response was not operative in the
disease course in the B6 animals. Similarly, the scid
mutation on the BALB/c and CB.17 backgrounds did not
allow the development of CNS disease in these strains of
mice. While these animals did eventually succumb to
disseminated MAV-1 infection, the brain was spared.
These results indicate that the immune response in the
BALB/c mouse is not the mechanism by which the CNS
vasculature is protected from viral infection in the resis-
tant mouse. These animals died from a disseminated
systemic infection with prominent involvement of the
liver, spleen, and intestinal tract, as described previously
(Pirofski et al., 1991). This observation implies that host
immunologic control of the viral infection is necessary for
the prevention of disseminated, systemic disease, but
not for control of the early, CNS phase of the disease.
These data would support the conclusion that BALB/c
mice are resistant to hemorrhagic encephalopathy by
virtue of differences in the pattern of MAV-1 replication
within CNS endothelial cells. Previous work from this
laboratory could not detect E1A mRNA in the CNS of
infected BALB/c animals (Guida et al., 1995). Thus, these
differences are likely the result of differences in MAV-1
receptor expression or the presence of a block at any of
the early steps prior to the synthesis of E1A mRNA.
In conclusion, we have identified the target cell for
replication of MAV-1 in susceptible strains of mice and
have shown that in the resistant BALB/c mouse the virus
fails to infect this cell to a significant extent. Infection of
cerebrovascular endothelial cells results in vascular
damage leading to hemorrhage and infarction. The fac-
tors controlling infection of cerebral endothelium in sus-
ceptible and resistant mice are unrelated to the acquired
immune response of the host, suggesting modulation of
an early replication step of MAV-1 in the target tissue.
METHODS AND MATERIALS
Cells and virus
Murine L929 (L cells) were obtained from the Ameri-
can Type Culture Collection (ATCC) and were grown in
Dulbecco’s modified Eagle’s medium (DMEM; Gibco
BRL) supplemented with 10% fetal calf serum, 2 mM
glutamine, 50 mg streptomycin, and 50 U penicillin/ml.
For production of virus, the concentration of FCS was
reduced to 3%. MAV-1 was grown in L cells, and titer was
determined by plaque assay on L cells as previously
described (Pirofski et al., 1991). Purified virus was pre-
pared by infection of L cells in suspension culture at an
m.o.i. of 0.01. After 5 days in culture, cells were pelleted,
and virus was liberated from cells by freeze/thaw and
Freon extraction. Virus was purified from the aqueous
phase of the Freon extraction by two rounds of equilib-
rium centrifugation in continuous CsCl gradients. Puri-
fied virus was stored at 220°C in 50% glycerol.
Mice
Five- or six-week-old female C57Bl/6, BALB/c, and
BALB/scid mice were obtained from Jackson Laborato-
ries (Bar Harbor, ME). CB.17/scid and CB.17/scid/beige
were obtained from Charles River (Wilmington, MA).
RAG-12/2 (C57B1/6 3 CD-1) were kindly provided by Dr.
F. Lilly (AECOM) and were derived from breeding stocks
supplied by Dr. S. Tonegawa (Toronto, Canada; Mom-
baerts et al., 1992). Mice were maintained in the Albert
Einstein College of Medicine (AECOM) Animal Institute
in microisolator cages, with food and water ad libitum on
a 12-h light/dark cycle. All animal experimentation was
performed in accordance with National Institutes of
Health guidelines, and animal protocols were approved
by the Animal Care and Use Committee of the AECOM.
Viral infections
Mice were inoculated by intraperitoneal injection of
5 3 103 or 1 3 104 PFU of MAV-1 (strain FL). At various
time points after infection, mice were deeply anesthe-
tized with sodium pentobarbital (Nembutal, Abbott Lab-
oratories, North Chicago, IL) and perfused transcardially
with phosphate-buffered saline (PBS). Tissues were im-
mersion fixed in Trump’s fixative (for light and electron
microscopy), homogenized in Tri-Reagent (for ribonucle-
ase protection assay), or homogenized at 50 mg/ml in
PBS (for viral titration).
Tissues for electron microscopy were postfixed in 2%
osmium tetroxide, dehydrated through graded ethanols,
and embedded in Epon resin (Electron Microscopy Sci-
ences, Ft. Washington, PA). Semithin sections were cut at
1 mm, dry mounted on glass slides, and stained with
toluidine blue. Areas of interest were selected by light
microscopy, and sectioned at 0.1 mm. Sections were
collected on copper grids, stained with uranyl acetate
and lead citrate, and visualized and photographed on a
Jeol 100S electron microscope.
Tissues for immunohistochemistry were embedded in
paraffin, sectioned at 5 mm, and mounted on glass
slides. Deparaffinized sections were stained overnight at
4°C in rabbit antiserum to MAV-1 diluted 1:500. Specific
staining was detected using the Vector Laboratories
(Burlingame, CA) ABC kit as described by the manufac-
turer. DAB substrate was from Pierce (Rockford, IL).
Ribonuclease protection assay
Ribonuclease protection assay (RPA) using the ml-11
probe cocktail was performed essentially as described
(Hobbs et al., 1993). Briefly, [32P]UTP-labeled antisense
RNA transcripts for TNF-a, lymphotoxin (LT), IFN-g, IL-1a,
IL-1b, IL-2, IL-3, IL-4, IL-5, IL-6, and L-32 (large ribosomal
subunit protein 32) were generated using the ml-11 tem-
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plates and T7 RNA polymerase. Twenty micrograms of
total RNA from each sample was allowed to hybridize to
the labeled probe for 20 h at 45°C. Single-stranded RNA
was digested with an RNase A/T1 mixture, and the hy-
brids were analyzed on denaturing urea/polyacrylamide
gels. Protected fragments were visualized by autoradiog-
raphy.
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Note added in proof. Since the submission of the manuscript, Kajon,
Brown, and Spindler have also demonstrated that MAV-1 displays a
tropism for vascular endothelial cells (Kajon, A. E., Brown, C. C., and
Spindler, K. R. (1998). Distribution of mouse adenovirus type 1 in
intraperitoneally and intranasally infected adult outbred mice. J. Virol.
72, 1219–1223).
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